FOLH1 and nonpapillary renal cell carcinoma: Bone metastases showed a significant increase of PSMA-radioligand uptake in ccRCC (median SUVmax 6.6 vs. 15.9; p = 0.008; median SUVmean 5.0 vs. 11.3; p = 0.006) but not in pRCC (median SUVmax 6.2 vs. 6.0; p = 0.86; median SUVmean 12.9 vs. 3.9; p = 0.38).